Infinity Pharmaceuticals Competitors and Similar CompaniesClear all
Iovance Biotherapeutics's competitors and similar companies include Kyowa Kirin.
 Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 2013 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US | |
Employees | Employees 14868% increase | Employees 5,669 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) 8.8 b |
Financial | ||
Revenue (est.) | Revenue (est.) $263.5m (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods $173.2m (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit $90.3m (FY, 2025) | Gross profit ¥383.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company